financetom
Business
financetom
/
Business
/
NanoViricides Says NV-387 Antiviral Drug Could Help Reduce Metastatic Cancer Resurgence
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NanoViricides Says NV-387 Antiviral Drug Could Help Reduce Metastatic Cancer Resurgence
Aug 18, 2025 6:23 AM

09:04 AM EDT, 08/18/2025 (MT Newswires) -- NanoViricides ( NNVC ) said Monday its NV-387 antiviral drug could help lower resurgence of metastatic cancer caused by awakening of "sleeping" cancer cells due to viral infections.

The biopharmaceutical company said the drug is being advanced into phase II trials following completion of a phase I trial.

Shares were up 2% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BYD appoints former Stellantis UK chief Davino to push European expansion
BYD appoints former Stellantis UK chief Davino to push European expansion
Nov 3, 2024
MILAN (Reuters) - BYD has appointed former Stellantis UK chief Maria Grazia Davino to lead its operations in a group of European countries including Germany, the Chinese automaker said on Wednesday. BYD, the second-largest producer of battery-electric cars globally, has been leading Chinese carmakers' push into Europe. It is also building factories in Hungary and Turkey to establish local manufacturing...
Bio-Techne Fiscal Q1 Adjusted Earnings, Net Sales Rise
Bio-Techne Fiscal Q1 Adjusted Earnings, Net Sales Rise
Nov 3, 2024
07:41 AM EDT, 10/30/2024 (MT Newswires) -- Bio-Techne ( TECH ) reported fiscal Q1 adjusted earnings Wednesday of $0.42 per diluted share, up from $0.41 a year earlier. Analysts polled by Capital IQ expected $0.38. Net sales for the quarter ended Sept. 30 were $289.5 million, up from $276.9 million a year earlier. Analysts surveyed by Capital IQ expected $280.1...
Brookfield Acquires Stakes in Four UK Offshore Wind Farms From Orsted
Brookfield Acquires Stakes in Four UK Offshore Wind Farms From Orsted
Nov 3, 2024
07:42 AM EDT, 10/30/2024 (MT Newswires) -- Brookfield Asset Management ( BAM ) has signed a partnership agreement with Orsted through which it will acquire 12.45% minority stakes in four of Orsted's UK offshore wind farms that have a combined total capacity of approximately 3.5 gigawatts, the companies said Wednesday. ...
Garmin raises full-year guidance, results beat amid unabated demand
Garmin raises full-year guidance, results beat amid unabated demand
Nov 3, 2024
Oct 30 (Reuters) - Garmin raised its full-year profit and revenue forecasts on Wednesday, expecting a slew of launches of wearable products ahead of the holiday season to drive demand further, sending the company's shares up 9.5% in premarket trading. Garmin's fitness segment, its second-largest by revenue, has seen resilient growth in the first half of the year, primarily driven...
Copyright 2023-2026 - www.financetom.com All Rights Reserved